大学ホーム医学部教員紹介岡田 アナベル あやめ

教員紹介:岡田 アナベル あやめ

氏名
 
岡田 アナベル あやめ
オカダ アナベル アヤメ OKADA, Annabelle A
職位 教授
学内の役職・委員等 女性研究者支援ワーキンググループ
所属教室 眼科学
専攻・専門分野
 (大学院)
外科系専攻 眼科学分野
担当科目(学部) 眼炎症(ぶどう膜炎、強膜炎など)、黄斑疾患(加齢黄斑変性、近視性黄斑症など)
担当科目(大学院) 眼炎症、眼免疫
専門分野 眼炎症(ぶどう膜炎)、黄斑疾患(加齢黄斑変性など)
研究テーマ 眼炎症や黄斑疾患の薬物療法
略歴 1983年 Harvard大学・生化学専攻卒業
1988年 Harvard大学医科大学院卒業
1988年 Harvard大学内科インターンシップ
1989年 Harvard大学眼科レジデンシー
1992年 東京医科大学眼科大学院・勤務
1998年 大阪大学医学部眼科助手
1999年 杏林大学医学部眼科講師
2002年 杏林大学医学部眼科助(准)教授
2009年 杏林大学医学部眼科教授
所有する学位 博士(医学)
指導医・専門医・認定医、その他の資格等 日本眼科学会眼科専門医認定
日本眼科学会指導医認定
光線力学療法認定
Medical License, State of California, USA
Medical License, State of Hawaii, USA
American Board of Ophthalmology眼科専門認定
論文・著書等を含む主要研究業績 1. Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Sekiryu T, Okada AA, Iida H. Aflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicenter study. Br J Ophthalmol 99:1284-1288, 2015.
2. Yamamoto A, Okada AA, Kano M, Koizumi H, Saito M, Maruko I, Sekiryu T, Iida T. One-year results of intravitreal aflibercept for polypoidal choroidal vasculopathy. Ophthalmology 122:1866-1872, 2015.
3. Denniston AK, Holland GN, Kidess A, Nussenblatt RB, Okada AA, Rosenbaum JT, Dick AD. Heterogeneity of primary outcome measures used in clinical trials of treatment for intermediate, posterior and panuveitis. Orphanet J Rare Dis 10:97, 2015.
4. Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Sekiryu T, Okada AA, Iida T. Subfoveal choroidal thickness during aflibercept therapy for neovascular age-related macular degeneration: 12-month results. Ophthalmology 123:617-624, 2016.
5. Keino H, Watanabe T, Sato Y, Shudo K, Kitaoka Y, Harada T, Okada AA. Retinoic acid receptor stimulation ameliorates experimental autoimmune optic neuritis. Clin Experiment Ophthalmol 43:558-567, 2015.
6. Higashi K, Meguro A, Takeuchi M, Yamane T, Kitaichi N, Horie Y, Namba K, Ohno S, Nakao K, Sakamoto T, Sakai T, Tsuneoka H, Keino H, Okada AA, Takeda A, Fukuhara T, Mashimo H, Ohguro N, Ohno S, Enaida H, Okinami S, Mizuki N. Investigation of association between IL10 gene polymorphisms and Vogt-Koyanagi-Harada disease in a Japanese population. Ophthalmic Genet 4:1-3, 2016.
7. Keino H, Okada AA, Watanabe T, Nakayama M, Nakamura T. Efficacy of infliximab for early remission induction in refractory uveoretinitis associated with Behcet’s disease: a 2-year follow-up study. Ocular Immuno Inflamm 25:46-51, 2017.
8. Keino H, Watanabe T, Taki W, Nakayama M, Nakamura T, Okada AA. Clinical features of uveitis in children and adolescents at a tertiary referral center in Tokyo. Br J Ophthalmol 101:406-410, 2017.
9. Yamamoto A, Okada AA, Nakayama M, Yoshida Y, Kobayashi H. One-year outcomes of a treat-and-extend regimen of aflibercept for exudative age-related macular degeneration. Ophthalmologica 237:139-144, 2017.
10. Hunyor AP, Merani R, Darbar A, Korobelnik JF, Lanzetta P, Okada AA. Topical antibiotics and intravitreal injections. Acta Ophthalmologica 96:435-441, 2018.
11. Jabs DA, Dick A, Doucette JT, Gupta A, Lightman S, McCluskey P, Okada AA, Palestine AG, Rosenbaum JT, Saleem SM, Thorne J, and Trusko B for the Standardization of Uveitis Nomenclature (SUN) Working Group. Interobserver agreement among uveitis experts on uveitic diagnoses: the Standardization of Uveitis Nomenclature (SUN) experience. Am J Ophthalmol 186:19-24, 2018.
12. Ogasawara M, Sekiryu T, Itagaki K, Saito M, Koizumi H, Maruko I, Yamamoto A, Okada AA, Iida T. Prognostic factors after aflibercept therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy. Jpn J Ophthalmol 62:584-591, 2018.
13. Watanabe T, Keino H, Nakayama K, Taki W, Echizen N, Okada AA. Clinical features of patients with diabetic anterior uveitis. Br J Ophthalmol 103:78-82, 2019.
14. Nakayama M, Keino H, Watanabe T, Okada AA. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids. Br J Ophthalmol 103:274-278, 2019.
15. Storey PP, Tauqeer Z, Yonekawa Y, Todorich B, Wolfe JD, Shah SP, Shah AR,
Koto T, Abbey AM, Morizane Y, Sharma P, Wood EH, Morizane-Hosokawa M, Pendri P, Pancholy M, Harkey S, Jeng-Miller KW, Obeid A, Borkar DS, Chen E, Williams P, Okada AA, Inoue M, Shiraga F, Hirakata A, Shah CP, Prenner J, Garg S, for the Post-Injection Endophthalmitis (PIE) Study Group. The impact of prefilled syringes on endophthalmitis following intravitreal injection of ranibizumab. Am J Ophthalmol 199:200-208, 2019.
16. Ando Y, Keino H, Kudo A, Hirakata A, Okada AA, Umezawa K. Anti-inflammatory effect of dehydroxymethylepoxyquinomicin, a nuclear factor-kB inhibitor, on endotoxin-induced uveitis in rats in vivo and in vitro. Ocular Immunol Inflamm 28:240-248, 2020.
17. Ando Y, Keino H, Nakayama M, Watanabe T, Okada AA. Clinical features, treatment, and visual outcomes of Japanese patients with posterior scleritis. Ocul Immunol Inflamm 28:209-216, 2020.
18. Ohji M, Takahashi K, Okada AA, Kobayashi M, Matsuda Y, Terano Y for the ALTAIR Investigators. Efficacy and safety of intravitreal aflibercept treat-and-extend regimens in exudative age-related macular degeneration: 52- and 96-week findings from ALTAIR. Adv Ther 37:1173-1187, 2020.
19. Korobelnik JF, Loewenstein A, Eldem B, Joussen AM, Koh A, Lambrou GN, Lanzetta P, Li X, Lovestam-Adrian M, Navarro R, Okada AA, Pearce I, Rodriguez FJ, Wong DT, Wu L. Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic. Graefes Arch Clin Exp Ophthalmol 258:1149-1156, 2020.
20. Ando Y, Sato Y, Kudo A, Watanabe T, Hirakata A, Okada AA, Umezawa K, Keino H. Anti-inflammatory effects of the NF-kB inhibitor dehydroxymethylepoxyquinomicin on ARPE-19 cells. Mol Med Rep 22:582-590, 2020.
所属学会 日本眼科学会
日本眼科医会
東京都眼科医会
日本眼科手術学会
日本眼炎症学会
日本網膜硝子体学会
Japan Macula Club
日本医学教育学会
日本国際医学協会
日本近視学会
American Academy of Ophthalmology
Massachusetts Medical Society
Association for Research in Vision and Ophthalmology
International Ocular Inflammation Society
International Uveitis Study Group
American Uveitis Society
Retina Society
学外活動 医学雑誌編集員(国内:新しい眼科,Japanese Journal of Ophthalmology.海外:Ocular Immunology and Inflammation)
関連サイト http://www.eye-center.org/
倫理委員会・利益相反
このページのトップへ

PAGE TOP